HistoSonics Announces Approval of its #HOPE4LIVER US Clinical Study
HistoSonics Lands $40M Series C-1 To Perfect Precision Therapy
HistoSonics Wins Top Honors in The Observer’s List of Top Healthcare Start-ups Heading into the JP Morgan Healthcare Conference
